Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Gross Margin (2020 - 2025)

Historic Gross Margin for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to 77.39%.

  • NeuroPace's Gross Margin rose 41700.0% to 77.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 76.77%, marking a year-over-year increase of 29500.0%. This contributed to the annual value of 73.94% for FY2024, which is 3900.0% up from last year.
  • Latest data reveals that NeuroPace reported Gross Margin of 77.39% as of Q3 2025, which was up 41700.0% from 77.09% recorded in Q2 2025.
  • NeuroPace's Gross Margin's 5-year high stood at 77.39% during Q3 2025, with a 5-year trough of 68.83% in Q4 2022.
  • For the 5-year period, NeuroPace's Gross Margin averaged around 73.84%, with its median value being 73.44% (2021).
  • In the last 5 years, NeuroPace's Gross Margin tumbled by -46100bps in 2022 and then skyrocketed by 63700bps in 2023.
  • Over the past 5 years, NeuroPace's Gross Margin (Quarter) stood at 73.44% in 2021, then dropped by -6bps to 68.83% in 2022, then grew by 9bps to 75.2% in 2023, then increased by 0bps to 75.41% in 2024, then grew by 3bps to 77.39% in 2025.
  • Its last three reported values are 77.39% in Q3 2025, 77.09% for Q2 2025, and 76.99% during Q1 2025.